ArticleBMC cancer2026

Pan-cancer analysis of TRPV1: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction.

Feixiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.